Sickle Cell Disease

How CRISPR Gene Editing Works to Treat Genetic Diseases

CRISPR-Cas9 gene editing technology, functioning as precise molecular scissors, offers a revolutionary approach to treating genetic diseases by modifying DNA. Its recent FDA approval for sickle cell disease marks a significant milestone, with ongoing research exploring broader applications and addressing challenges in delivery and safety.